Evidence map›Paper›PMID 19941976›Full record

ReviewAgeing research reviews2011

Age-related defects in the cytoskeleton signaling pathways of CD4 T cells.

Gonzalo G Garcia, Richard A Miller

Abstract readReview
In one paragraph

Review in Ageing research reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Possibilities of using T-cell biophysical biomarkers of ageing.Expert reviews in molecular medicine · 2022
    Review
  5. Article
  6. Article
  7. The cellular mechanobiology of aging: from biology to mechanics.Annals of the New York Academy of Sciences · 2021
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Causes, consequences, and reversal of immune system aging.The Journal of clinical investigation · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Gonzalo G GarciaDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, MI, United States. gonzola@umich.edu
Richard A Miller
Michigan Medicine · USUniversity of Michigan–Ann Arbor · US

Funding

Activation Defects in T Cells of Aged MiceR01AG019619 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MILLER, RICHARD A · 2000 to 2011
$3.5M
ERM and Rho Signal Pathways in T Cell Immune SenescenceR21AG030828 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GARCIA, GONZALO GARCIA · 2007 to 2008
$339k
NIA NIH HHS AG019619NIA NIH HHS AG030828NIA NIH HHS R01 AG019619NIA NIH HHS R21 AG030828
6 · The paper itself

Abstract

It has been postulated that the cytoskeleton controls many aspects of T cell function, including activation, proliferation and apoptosis. Recent advances in our understanding of F-actin polymerization and the Ezrin-Radixin-Moesin (ERM) family of cytoskeleton signal proteins have provided new insights into immunological synapse formation during T cell activation. During aging there is a significant decline of T cell function largely attributable to declines in activation of CD4 T cells and defects in the formation of the immunological synapse. Here we discuss recent progress in the understanding of how aging alters F-actin and ERM proteins in mouse CD4 T cells, and the implications of these changes for the T cell activation process.

Indexed as

AgingAnimalsCD4-Positive T-LymphocytesCytoskeletal ProteinsCytoskeletonHumansSignal TransductionCytoskeletal Proteins

Identifiers

PMID19941976
PMCPMC2888705
OpenAlexW2008369123

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.